1. Home
  2. ETON vs NOA Comparison

ETON vs NOA Comparison

Compare ETON & NOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • NOA
  • Stock Information
  • Founded
  • ETON 2017
  • NOA 1953
  • Country
  • ETON United States
  • NOA Canada
  • Employees
  • ETON N/A
  • NOA N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • NOA Meat/Poultry/Fish
  • Sector
  • ETON Health Care
  • NOA Consumer Staples
  • Exchange
  • ETON Nasdaq
  • NOA Nasdaq
  • Market Cap
  • ETON 498.8M
  • NOA 478.5M
  • IPO Year
  • ETON 2018
  • NOA 2006
  • Fundamental
  • Price
  • ETON $16.95
  • NOA $13.25
  • Analyst Decision
  • ETON Strong Buy
  • NOA
  • Analyst Count
  • ETON 3
  • NOA 0
  • Target Price
  • ETON $29.67
  • NOA N/A
  • AVG Volume (30 Days)
  • ETON 278.7K
  • NOA 83.2K
  • Earning Date
  • ETON 11-06-2025
  • NOA 11-12-2025
  • Dividend Yield
  • ETON N/A
  • NOA 2.61%
  • EPS Growth
  • ETON N/A
  • NOA N/A
  • EPS
  • ETON N/A
  • NOA 0.87
  • Revenue
  • ETON $70,316,000.00
  • NOA $919,386,154.00
  • Revenue This Year
  • ETON $105.25
  • NOA $12.11
  • Revenue Next Year
  • ETON $40.84
  • NOA $6.50
  • P/E Ratio
  • ETON N/A
  • NOA $15.07
  • Revenue Growth
  • ETON 102.77
  • NOA 14.15
  • 52 Week Low
  • ETON $8.43
  • NOA $12.12
  • 52 Week High
  • ETON $23.00
  • NOA $22.08
  • Technical
  • Relative Strength Index (RSI)
  • ETON 38.74
  • NOA 38.16
  • Support Level
  • ETON $16.34
  • NOA $13.62
  • Resistance Level
  • ETON $18.15
  • NOA $14.32
  • Average True Range (ATR)
  • ETON 1.08
  • NOA 0.58
  • MACD
  • ETON -0.14
  • NOA -0.17
  • Stochastic Oscillator
  • ETON 14.34
  • NOA 9.08

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About NOA North American Construction Group Ltd. (no par)

North American Construction Group Ltd is Canada's heavy civil construction and mining contractor provider. The company has provided services to oil, natural gas, and resource companies. The Company provides a wide range of mining and heavy civil construction services to customer in the resource development and industrial construction sectors within Canada, the United States, and Australia. The Company's reportable segments are Heavy Equipment Canada, Heavy Equipment Australia, and Other. Heavy Equipment Canada and Heavy Equipment Australia include all of aspects of the mining and heavy civil construction services provided within those geographic areas. Other includes mine management contract work in the United States, its external maintenance and rebuild programs.

Share on Social Networks: